(Q35838958)

10 August 2017

1 reference

title

Chemotherapy-induced peripheral neuropathy: pathogenesis and emerging therapies (English)

1 reference

10 August 2017

1 reference

peripheral neuropathy

1 reference

Chemotherapy-induced peripheral neuropathy

inferred from title

1 reference

2

Linda T Vahdat

1 reference

10 August 2017

Allyson J Ocean

1

1 reference

10 August 2017

publication date

1 September 2004

1 reference

Supportive Care in Cancer

10 August 2017

published in

1 reference

10 August 2017

volume

12

1 reference

10 August 2017

issue

9

1 reference

10 August 2017

page(s)

619-625

1 reference

https://scigraph.springernature.com/pub.10.1007/s00520-004-0657-7

10 August 2017

exact match

0 references

cites work

Vincristine Neurotoxicity: A Clinical and Electrophysiological Study of Eighteen Patients

1 reference

12 December 2020

Cisplatin-induced apoptosis of DRG neurons involves bax redistribution and cytochrome c release but not fas receptor signaling

1 reference

12 December 2020

Grading of chemotherapy-induced peripheral neuropathy

1 reference

12 December 2020

Acute deterioration of Charcot-Marie-Tooth disease IA (CMT IA) following 2 mg of vincristine chemotherapy

1 reference

12 December 2020

Prevention of cisplatin neurotoxicity with an ACTH(4-9) analogue in patients with ovarian cancer

1 reference

12 December 2020

Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies

1 reference

12 December 2020

Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer

1 reference

12 December 2020

Venlafaxine in neuropathic pain following treatment of breast cancer

1 reference

12 December 2020

Delayed functional recovery by vincristine after sciatic nerve crush injury: a mouse model of vincristine neurotoxicity

1 reference

12 December 2020

Glutamine nutrition and requirements

1 reference

12 December 2020

Claude H. Organ, Jr. Honorary Lectureship. Glutamine, cancer, and its therapy

1 reference

12 December 2020

Glutamine treatment of paclitaxel-induced myalgias and arthralgias

1 reference

12 December 2020

Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer

1 reference

12 December 2020

Managing the neurotoxicity of paclitaxel (Taxol) and docetaxel (Taxotere) with neurotrophic factors

1 reference

12 December 2020

Amifostine: chemotherapeutic and radiotherapeutic protective effects

1 reference

12 December 2020

Chemotherapy-induced peripheral neuropathy

1 reference

12 December 2020

Neuroprotective effect of reduced glutathione on cisplatin-based chemotherapy in advanced gastric cancer: a randomized double-blind placebo-controlled trial

1 reference

12 December 2020

Toxic neuropathy in patients with pre-existing neuropathy

1 reference

12 December 2020

Approach to peripheral neuropathy and neuronopathy

1 reference

12 December 2020

Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer: a randomized, double-blind, placebo-controlled trial

1 reference

12 December 2020

Reduction of paclitaxel-induced peripheral neuropathy with glutamine

1 reference

12 December 2020

Bilateral facial nerve palsy secondary to the administration of high-dose paclitaxel

1 reference

12 December 2020

Pitfalls in grading severity of chemotherapy-induced peripheral neuropathy.

1 reference

12 December 2020

Vincristine neuropathy. Clinical and electrophysiological observations

1 reference

12 December 2020

Nerve growth factor rescue of cisplatin neurotoxicity is mediated through the high affinity receptor: studies in PC12 cells and p75 null mouse dorsal root ganglia

1 reference

12 December 2020

Pharmacokinetics and safety profile of oxaliplatin

1 reference

12 December 2020

Phase I trial of 3-hour infusion of paclitaxel with or without granulocyte colony-stimulating factor in patients with advanced cancer

1 reference

12 December 2020

Toxicity and response criteria of the Eastern Cooperative Oncology Group

1 reference

12 December 2020

Vincristine neuropathy in type I and type II charcot‐marie‐tooth disease (hereditary motor sensory neuropathy)

1 reference

12 December 2020

Effect of cisplatin and ACTH4-9 on neural transport in cisplatin induced neurotoxicity

1 reference

12 December 2020

Morphological and pharmacological evidence for the role of peripheral prostaglandins in the pathogenesis of neuropathic pain

1 reference

12 December 2020

Vincristine-induced allodynia in the rat.

1 reference

12 December 2020

Clinical toxicities encountered with paclitaxel (Taxol).

1 reference

12 December 2020

Weekly cisplatin +- glutathione in relapsed ovarian carcinoma

1 reference

12 December 2020

2002 update of recommendations for the use of chemotherapy and radiotherapy protectants: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

12 December 2020

A randomised double-blind placebo controlled clinical trial assessing the tolerability and efficacy of glutathione as an adjuvant to escalating doses of cisplatin in the treatment of advanced ovarian cancer.

1 reference

12 December 2020

Recent advances in drug-induced neuropathies

1 reference

12 December 2020

Acute oxaliplatin-induced peripheral nerve hyperexcitability

1 reference

12 December 2020

Polyneuropathy after neurosedyn (thalidomide) and its prognosis

1 reference

12 December 2020

Thalidomide-induced neuropathy

1 reference

12 December 2020

The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine.

1 reference

12 December 2020

Chemoprotectants: a review of their clinical pharmacology and therapeutic efficacy.

1 reference

12 December 2020

Phase I study of oxaliplatin in patients with advanced cancer

1 reference

12 December 2020

Reporting results of cancer treatment

1 reference

12 December 2020

Thalidomide neuropathy in the late stage. A clinical documentation

1 reference

12 December 2020

Oxaliplatin: mechanism of action and antineoplastic activity

1 reference

12 December 2020

The course of neuropathy after cessation of cisplatin treatment, combined with Org 2766 or placebo

1 reference

12 December 2020

The effects of an ACTH (4-9) analogue on development of cisplatin neuropathy in testicular cancer: a randomized trial

1 reference

12 December 2020

Randomized phase II study of high-dose paclitaxel with or without amifostine in patients with metastatic breast cancer

1 reference

12 December 2020

10.1007/S00520-004-0657-7

Identifiers

DOI

0 references

1 reference